5N17
First Bromodomain (BD1) from Candida albicans Bdf1 bound to a dibenzothiazepinone (compound 3)
Summary for 5N17
Entry DOI | 10.2210/pdb5n17/pdb |
Descriptor | Bromodomain-containing factor 1, (2~{S})-~{N}-(5-methyl-6-oxidanylidene-benzo[b][1,4]benzothiazepin-2-yl)oxolane-2-carboxamide, SULFATE ION, ... (4 entities in total) |
Functional Keywords | bromodomain, transcription |
Biological source | Candida albicans (Yeast) |
Cellular location | Nucleus : Q5A4W8 |
Total number of polymer chains | 2 |
Total formula weight | 31975.07 |
Authors | Mietton, F.,Ferri, E.,Champleboux, M.,Zala, N.,Maubon, D.,Zhou, Y.,Harbut, M.,Spittler, D.,Garnaud, C.,Courcon, M.,Chauvon, M.,d'Enfer, C.,Kashemirov, B.A.,Hull, M.,Cornet, M.,McKenna, C.E.,Govin, J.,Petosa, C. (deposition date: 2017-02-05, release date: 2017-05-31, Last modification date: 2024-01-17) |
Primary citation | Mietton, F.,Ferri, E.,Champleboux, M.,Zala, N.,Maubon, D.,Zhou, Y.,Harbut, M.,Spittler, D.,Garnaud, C.,Courcon, M.,Chauvel, M.,d'Enfert, C.,Kashemirov, B.A.,Hull, M.,Cornet, M.,McKenna, C.E.,Govin, J.,Petosa, C. Selective BET bromodomain inhibition as an antifungal therapeutic strategy. Nat Commun, 8:15482-15482, 2017 Cited by PubMed: 28516956DOI: 10.1038/ncomms15482 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report